Medtech Spectrum: Discovering the Intersection of Medical Technology and Healthcare Advancements

Article Name Med Special

Trump’s Comeback: What MedTech Needs to Brace For and Capitalize On

From Deregulation to Tax Cuts, Trump’s Policies Could Redefine the MedTech Landscape — But Are Companies Ready?...Read more

08th November, 2024 | By Ankit Kankar | ankit.kankar@mmactiv.com

AiMeD hails Union Budget-2024; will give a boost to overall economic growth: Rajiv Nath

Medical devices industry was expecting more for quality and affordable healthcare: AiMeD Forum Coordinator Rajiv Nath...Read more

23rd July, 2024

MedTech Industry Surpasses $42 Billion in R&D Investment, Drives Growth Through Strategic M&A Deals

COVID-19 Accelerates Demand for Diagnostics, Fuels Robust Sector Growth; Major Deals by Johnson & Johnson, BD, and Danaher Highlight Expansion and Innovation Strategies....Read more

27th June, 2024 | By Sakshi Kamble | sakshi.kamble@biospectrumasia.com

Urology of Virginia Announces New Chief Executive Officer

Dr. Joshua Langston Assumes Role of Managing Partner and CEO at Urology of Virginia...Read more

02nd January, 2024 | By Vrushti Kothari

NEOM is fundamentally reshaping health by placing a strong emphasis on personalised care

The core of a holistic health reform lies in the integration of emerging cutting-edge technologies into personalised care, emphasising interdisciplinary approaches. To fulfil the burgeoning healthcare requirement, Saudi ...Read more

06th November, 2023

Disruptive Technologies and New Industry Initiatives for Diabetes Management

Asia will continue to be a large and rapidly growing market for diabetes care technologies. To be competitive and successful in the aggressive market with numerous large and startup companies, players will need large fun...Read more

06th November, 2023 | By Dr Sneha Maria, Industry Analyst, Medical Devices and Imaging-TechVision, Frost and Sullivan

Roche Acquires Telavant and TL1A Antibody for Inflammatory Bowel Disease

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc....Read more

24th October, 2023

Roche's Fenebrutinib Shows Brain Penetration and Lesion Reduction in Multiple Sclerosis Patients: Late-breaking Data

Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent s...Read more

14th October, 2023

Is It That Time of Year for Seasonal Infections? Exploring the Seasonal Patterns of Common Illnesses

As the leaves turn golden and temperatures begin to drop, many of us start to wonder: is it that time of year for seasonal infections? The changing seasons have long been associated with an uptick in certain illnesses, l...Read more

20th September, 2023 | By Ankit Kankar | ankit.kankar@mmactiv.com

Lunit AI Poised to Replace One Human Reader in Breast Cancer Screening, Study Validates

- Lunit's collaborative study supports AI as a viable alternative to one human reader in Europe's double reading system - published in The Lancet Digital Health...Read more

12th September, 2023